Ilan Daskal - Aug 4, 2021 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
EVP, Chief Financial Officer
Signature
/s/ Ilan Daskal
Stock symbol
BIO
Transactions as of
Aug 4, 2021
Transactions value $
-$1,295,465
Form type
4
Date filed
8/5/2021, 12:38 PM
Previous filing
Jun 21, 2021
Next filing
Sep 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $434K +1.4K +154.36% $309.84 2.31K Aug 4, 2021 Direct
transaction BIO Bio-Rad A Common Stock Sale -$643K -857 -37.15% $750.85 1.45K Aug 4, 2021 Direct F1
transaction BIO Bio-Rad A Common Stock Sale -$717K -954 -65.79% $751.98 496 Aug 4, 2021 Direct F2
transaction BIO Bio-Rad A Common Stock Sale -$368K -489 -98.59% $753.32 7 Aug 4, 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.4K -40% $0.00 2.1K Aug 4, 2021 Bio-Rad A Common Stock 1.4K $309.84 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $750.77 to $751.39, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $751.98 to $752.22, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $753.28 to $753.40, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The option, representing a right to purchase a total of 3,500 shares, became exercisable in five equal annual installments beginning on April 8, 2020, which was the first anniversary of the date on which the option was granted.